Advisory Board


The Master of Science in Biomedical Regulatory Affairs program is guided by an advisory board. Board members represent a cross section of the professional community and include representatives from pharmaceutical and device companies, research institutions and the FDA. Advisory board members help guide course design and review course content to ensure the program remains current as the field evolves.

Christopher Bentsen, Manager, Regulatory Affairs/Quality Assurance, Bio-Rad Laboratories

James Cross, Regulatory Program Director, Genentech

Marta Fields, Senior Director, Compliance and Quality Systems, Seattle Genetics

Jill Herendeen, Director, Regulatory Affairs, Pharmacyclics

Ed Kelly, Associate Professor, Department of Pharmaceutics, University of Washington

Marcia Koren, Proprietor, GCP Compliance Consulting

Mihaly Ligmond, U.S. Food and Drug Administration

Robert Mackey, Regulatory Director and Regional Manager, Harris Group

Royce Morrison, Executive Vice-Chair, Quorum Review IRB

David Pettenski, Supervisor, Medical Device Group, U.S. Food and Drug Administration

Terry Sweeney, Vice President, Global Clinical Affairs, Philips Healthcare

Wayne Tsuji, Medical Director, Amgen

Kirsten Vadheim, Principal Consultant, BioCompliance

Andy Walker, Senior Vice President, Manufacturing, Juno Therapeutics